Right now the price per share is 36,85$, In this post we are going to talk about the listed company Gemini Therapeutics Inc, its leaders are Brian Piekos (Chief Financial & Accounting Officer), Jason Meyenburg (President, CEO, Secretary & Director), Suresh Katti (Vice President-Research), Walter Strapps (Chief Scientific Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 35,57$ - 36,94$, with a percentage difference of 36,26$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
